Examining Genetic Influence on Response to Beta-Blocker Medications in People With Type 2 Diabetes

Summary

Beta-blockers are medications used to treat cardiovascular disease (CVD) symptoms, including high blood pressure and chest pain. People with diabetes who receive beta-blockers may experience adverse health effects, but the exact cause of why this happens remains unknown. This study will examine the genetic factors that may influence how atenolol, a beta-blocker medication, affects fat breakdown, blood sugar levels, and heart function in people with type 2 diabetes.

Timeline

Start

2009-12

Primary completion

2013-06

Completion

2014-05

Drugs

Indications